Slideshow
Author(s):
These apps are designed to improve treatment adherence, language skills, symptom tracking, communication, and other helpful functions.
A Changing Clinical Landscape: Promising Therapeutic Avenues in the Treatment of DIPG and Other Diffuse Midline Gliomas
Episode 132: Aiding Diagnosis of Synucleinopathies Through SAAmplify-aSYN Biomarker Test
Insights From the TRAILBLAZER-ALZ Program: Elevated ARIA Risk with Donanemab Highlights the Need for Vigilant Monitoring
Neurology Unwrapped: 2024’s Most Intriguing Conversations
Blueprints for Better Care: 2024 Neurology Guideline Highlights
FDA Action Update, February 2025: Approvals, Designations, and Acceptances